Article(id=1329526903783928307, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329526884620153211, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.04.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1704729600000, receivedDateStr=2024-01-09, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913515277, onlineDateStr=2026-11-17, pubDate=1712678400000, pubDateStr=2024-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913515277, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913515277, creator=13701087609, updateTime=1794913515277, updator=13701087609, issue=Issue{id=1329526884620153211, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='4', pageStart='349', pageEnd='444', issueExtLink='null', onlineDate='null', pubDate='1712678400000', pubDateStr='2024-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913510708, creator='13701087609', updateTime=1794962107180, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329730713529725122, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329526884620153211, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329730713529725123, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329526884620153211, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=368, endPage=371, ext={EN=ArticleExt(id=1329526904035586548, articleId=1329526903783928307, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances of clinical research on alternative therapy for hemophilia A, coagulation factor Ⅷ, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Hemophilia A (HA) is a rare X-chromosome linked recessive hemorrhagic disorder caused by the deficiency or dysfunction of coagulation factor Ⅷ (FⅧ) in the blood. The incidence of HA is low, the cost of treatment is high, and there is no effective radical treatment at present. On-demand alternative treatment is still the most effective way to treat HA in our country. However, HA patients need lifelong medication, the existing drugs have short half-life, high injection frequency, easy to produce coagulation FⅧ inhibitors, and poor quality of life of patients. In view of such unmet clinical needs, this paper mainly reviewed the clinical research progress of three alternative therapeutic drugs: plasma-derived human coagulation FⅧ, recombinant human coagulation FⅧ and long-acting recombinant human coagulation FⅧFc fusion protein, to provide new ideas and basis for later drug development and clinical treatment.

, authors=Zhilong LAN1, Chunyu CHEN2, Dandan ZHAO2, Meng ZHANG2, Junlong WANG1, *, Na NI1, *, authorsList=Zhilong LAN, Chunyu CHEN, Dandan ZHAO, Meng ZHANG, Junlong WANG, Na NI, authorCompany=null, correspAuthors=Junlong WANG, Na NI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329526904262078965, articleId=1329526903783928307, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=A型血友病替代治疗药物凝血因子Ⅷ的临床研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

A型血友病(hemophilia A,HA)是一种罕见的X染色体连锁隐性遗传性出血性疾病,因血液中凝血因子Ⅷ(factorⅧ,FⅧ)缺乏或者功能障碍所致。其发病率低,治疗费用高,且目前暂无有效的根治方法,按需替代治疗仍然是我国治疗HA最有效的方式。但目前HA患者需要终身用药,现有的药物半衰期短、注射频次高,易产生FⅧ抑制物,且患者的生存质量差。针对这种未被满足的临床需求,该文主要综述血源性人FⅧ、重组人FⅧ及长效重组人FⅧ-Fc融合蛋白3种替代治疗药物的临床研究进展,为后期药物研发及临床治疗提供新的思路和依据。

, authors=兰志龙1, 陈春宇2, 赵丹丹2, 张梦2, 王俊龙1, *, 倪娜1, *, authorsList=兰志龙, 陈春宇, 赵丹丹, 张梦, 王俊龙, 倪娜, authorCompany=null, correspAuthors=王俊龙, 倪娜, authorNote=

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

, correspAuthorsNote=
倪娜,副研究员,研究方向:创新药物的临床研究。
王俊龙,副研究员,研究方向:创新药物的临床研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=eUTUQ++NHlg9AXcDr9b0jA==, magXml=urfHH55Kyq4/gpAFJieyjQ==, pdfUrl=null, pdf=XfEjMwTacKh6ALsFQiIsxw==, pdfFileSize=1516404, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=rBABKLVobX5FQFNHEDOxSw==, mapNumber=null, fund=null)}, authors=[Author(id=1329526904643760637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526904727646719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904643760637, language=EN, stringName=Zhilong LAN, firstName=Zhilong, middleName=null, lastName=LAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526904803144192, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904643760637, language=CN, stringName=兰志龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

"}, bioImg=null, bioContent=

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904467599862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=1., ext=[AuthorCompanyExt(id=1329526904475988471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329526904484377080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329526904887030274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526906510225924, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904887030274, language=EN, stringName=Chunyu CHEN, firstName=Chunyu, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526906841575941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904887030274, language=CN, stringName=陈春宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904559874553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=2., ext=[AuthorCompanyExt(id=1329526904564068858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329526904572457467, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329526907047096839, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526907143565833, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907047096839, language=EN, stringName=Dandan ZHAO, firstName=Dandan, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526907240034826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907047096839, language=CN, stringName=赵丹丹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904559874553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=2., ext=[AuthorCompanyExt(id=1329526904564068858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329526904572457467, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329526907349086732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526907432972814, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907349086732, language=EN, stringName=Meng ZHANG, firstName=Meng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526907512664591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907349086732, language=CN, stringName=张梦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904559874553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=2., ext=[AuthorCompanyExt(id=1329526904564068858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329526904572457467, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329526907613327889, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329526907697213971, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907613327889, language=EN, stringName=Junlong WANG, firstName=Junlong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526907797877268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907613327889, language=CN, stringName=王俊龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904467599862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=1., ext=[AuthorCompanyExt(id=1329526904475988471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329526904484377080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329526907881763350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329526907978232344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907881763350, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526908074701337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907881763350, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904467599862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=1., ext=[AuthorCompanyExt(id=1329526904475988471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329526904484377080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])])], keywords=[Keyword(id=1329526908183753242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=EN, orderNo=1, keyword=hemophilia A), Keyword(id=1329526908271833627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=EN, orderNo=2, keyword=replacement therapy), Keyword(id=1329526908355719708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=EN, orderNo=3, keyword=plasma-derived human coagulation factor Ⅷ), Keyword(id=1329526908431217181, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=EN, orderNo=4, keyword=recombinant human coagulation factor Ⅷ), Keyword(id=1329526908527686174, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=EN, orderNo=5, keyword=reombint human coagulation factor Ⅷ-Fc fusion protein), Keyword(id=1329526908603183647, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=CN, orderNo=1, keyword=A型血友病), Keyword(id=1329526908687069728, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=CN, orderNo=2, keyword=替代治疗), Keyword(id=1329526908762567201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=CN, orderNo=3, keyword=血源性人凝血因子Ⅷ), Keyword(id=1329526908863230498, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=CN, orderNo=4, keyword=重组人凝血因子Ⅷ), Keyword(id=1329526908938727971, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, language=CN, orderNo=5, keyword=长效重组人凝血因子Ⅷ-Fc融合蛋白)], refs=[Reference(id=1329526909031002660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia[J]. Haemophilia, 2013, 19(1): e1-e47., articleTitle=null, refAbstract=null), Reference(id=1329526909098111525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Schmitt C, Mancuso ME, Chang T, et al. Emicizumab dose up-titration in case of suboptimal bleeding control in people with haemophilia A[J]. Haemophilia, 2023, 29(1): 90-99, articleTitle=null, refAbstract=null), Reference(id=1329526909190386214, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications[J]. Lancet, 2016, 388(10040): 187-197., articleTitle=null, refAbstract=null), Reference(id=1329526909324603943, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=中华人民共和国国家卫生健康委员会. 血友病A诊疗指南(2022年版)[J]. 全科医学临床与教育, 2022, 20(7): 579-583., articleTitle=null, refAbstract=null), Reference(id=1329526910972965416, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=屈泽欣, 肖剑文. 血友病A的治疗进展[J]. 临床医学进展, 2023, 13(3): 3973-3978., articleTitle=null, refAbstract=null), Reference(id=1329526911186874921, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=王稳, 胡群. 血友病患者关节评估及治疗的研究进展[J]. 国际输血及血液学杂志, 2021, 44(5): 456-460., articleTitle=null, refAbstract=null), Reference(id=1329526911421755946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Milanesio M, Tabares AH, Caeiro GA, et al. Acquired hemophilia[J]. Rev Fac Cien Med Univ Nac Cordoba, 2022, 79(1): 57-60., articleTitle=null, refAbstract=null), Reference(id=1329526911497253419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=陈如意, 吴燕, 刘依润, 等. 评价人凝血因子Ⅷ治疗甲型血友病患者的有效性和安全性[J]. 中国输血杂志, 2022, 35(12): 1220-1225., articleTitle=null, refAbstract=null), Reference(id=1329526911576945197, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Ebbert PT, Xavier F, Seaman CD, et al. Emicizumab prophylaxisin patients with haemophilia A with and without inhibitors[J]. Haemophilia, 2020, 26(1): 41-46., articleTitle=null, refAbstract=null), Reference(id=1329526911681802798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=杨仁池. 甲型血友病患者预防治疗的重要性[J]. 临床药物治疗杂志, 2019, 17(11): 11-13., articleTitle=null, refAbstract=null), Reference(id=1329526911748911663, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=张建华, 董春霞, 张爱荣, 等. 血浆源性人凝血因子Ⅷ治疗血友病A有效性和安全性多中心Ⅲ期临床研究[J]. 中华内科杂志, 2016, 55(8): 624-627., articleTitle=null, refAbstract=null), Reference(id=1329526911845380656, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Wynn TT, Gumuscu B. Potential role of a new PEGylated recombinant factor Ⅷ for hemophilia A[J]. J Blood Med, 2016, 7: 121-128., articleTitle=null, refAbstract=null), Reference(id=1329526911912489521, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心. 注射用重组人凝血因子Ⅷ(CXSS1900043)申请上市技术审评报告[EB/OL]. [2024-01-09]. https://www.cde.org.cn/main/xxgk/postmarketpage?acceptidCODE=19ca9a9923f87cc8eb8fbd759529a9f4., articleTitle=null, refAbstract=null), Reference(id=1329526912008958514, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Chhabra ES, Liu T, Kulman J, et al. BIVV001, a new class of factor Ⅷ replacement for hemophilia A that is independent of von willebrand factor in primates and mice[J]. Blood, 2020, 135(17): 1484-1496., articleTitle=null, refAbstract=null), Reference(id=1329526912088650291, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=周琪. 重组人凝血因子Ⅷ预防治疗甘肃地区重型血友病A患者的有效性和安全性观察[D]. 兰州: 兰州大学, 2020., articleTitle=null, refAbstract=null), Reference(id=1329526912155759156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Quon DV, Klamroth R, Kulkarni R, et al. Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor Ⅷ Fc fusion protein (rFⅧFc) in the A-LONG and kids A-LONG studies[J]. Haemophilia, 2017, 23(1): e39-e42., articleTitle=null, refAbstract=null), Reference(id=1329526912231256629, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=European Medicines Agency. First gene therapy to treat severe haemophilia A.[EB/OL]. [2024-01-09]. https://www.ema.europa.eu/en/news/first-gene-therapy-treat-severe-haemophilia., articleTitle=null, refAbstract=null), Reference(id=1329526912315142710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Frampton JE. Efmoroctocog α: a review in haemophilia A[J]. Drugs, 2021, 81(17): 2035-2046., articleTitle=null, refAbstract=null), Reference(id=1329526912386445879, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Peters RT, Toby G, Lu Q, et al. Biochemical and functional characterization of a recombinant monomeric factor Ⅷ-Fc fusion protein[J]. J Thromb Haemost, 2013, 11(1): 132-141., articleTitle=null, refAbstract=null), Reference(id=1329526912457749048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Tiede A. Half-life extended factor Ⅷ for the treatment of hemophilia A[J]. J Thromb Haemost, 2015, 13(Suppl 1): S176-S179., articleTitle=null, refAbstract=null), Reference(id=1329526912529052217, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Xue F, Chen Y, Sun J, et al. A phase 1 study to evaluate the pharmacokinetics and safety of a PEGylated-recombinant human coagulation factor Ⅷ-Fc fusion protein in patients with severe hemophilia A[EB/OL]. [2024-01-09]. https://isth2023.eventscribe.net/fsPopup.asp?PresentationID=1257997&mode=presInfo., articleTitle=null, refAbstract=null), Reference(id=1329526912604549690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Mahlangu J, Powell JS, Ragni MV, et al. Phase 3 study of recombinant factor Ⅷ Fc fusion protein in severe hemophilia A[J]. Blood, 2014, 123(3): 317-325., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329526904467599862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=1., ext=[AuthorCompanyExt(id=1329526904475988471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329526904484377080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1329526904559874553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=2., ext=[AuthorCompanyExt(id=1329526904564068858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329526904572457467, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.04.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.04.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.04.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.04.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1712678400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
A型血友病替代治疗药物凝血因子Ⅷ的临床研究进展
兰志龙 1 , 陈春宇 2 , 赵丹丹 2 , 张梦 2 , 王俊龙 1, * , 倪娜 1, *
世界临床药物 | 医药专论 2024,45(4): 368-371
收起
收藏切换
世界临床药物 |医药专论 2024 , 45 (4) : 368 -371
A型血友病替代治疗药物凝血因子Ⅷ的临床研究进展
全屏
[Author(id=1329526904643760637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526904727646719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904643760637, language=EN, stringName=Zhilong LAN, firstName=Zhilong, middleName=null, lastName=LAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526904803144192, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904643760637, language=CN, stringName=兰志龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

"}, bioImg=null, bioContent=

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904467599862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=1., ext=[AuthorCompanyExt(id=1329526904475988471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329526904484377080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329526904887030274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526906510225924, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904887030274, language=EN, stringName=Chunyu CHEN, firstName=Chunyu, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526906841575941, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526904887030274, language=CN, stringName=陈春宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904559874553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=2., ext=[AuthorCompanyExt(id=1329526904564068858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329526904572457467, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329526907047096839, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526907143565833, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907047096839, language=EN, stringName=Dandan ZHAO, firstName=Dandan, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526907240034826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907047096839, language=CN, stringName=赵丹丹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904559874553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=2., ext=[AuthorCompanyExt(id=1329526904564068858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329526904572457467, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329526907349086732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329526907432972814, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907349086732, language=EN, stringName=Meng ZHANG, firstName=Meng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526907512664591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907349086732, language=CN, stringName=张梦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海益临思医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904559874553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=2., ext=[AuthorCompanyExt(id=1329526904564068858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China), AuthorCompanyExt(id=1329526904572457467, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904559874553, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益临思医药开发有限公司,上海 200437)])]), Author(id=1329526907613327889, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329526907697213971, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907613327889, language=EN, stringName=Junlong WANG, firstName=Junlong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526907797877268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907613327889, language=CN, stringName=王俊龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904467599862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=1., ext=[AuthorCompanyExt(id=1329526904475988471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329526904484377080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1329526907881763350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329526907978232344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907881763350, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329526908074701337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, authorId=1329526907881763350, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329526904467599862, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, xref=1., ext=[AuthorCompanyExt(id=1329526904475988471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329526904484377080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329526903783928307, companyId=1329526904467599862, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])])]
兰志龙1, 陈春宇2, 赵丹丹2, 张梦2, 王俊龙1, *, 倪娜1, *
作者信息
  • 1.中国医药工业研究总院药物临床研究中心,上海 200437
  • 2.上海益临思医药开发有限公司,上海 200437
通讯作者:
倪娜,副研究员,研究方向:创新药物的临床研究。
王俊龙,副研究员,研究方向:创新药物的临床研究。
作者简介:

兰志龙,硕士研究生,研究方向:临床药学及临床研究。

Advances of clinical research on alternative therapy for hemophilia A, coagulation factor Ⅷ
Zhilong LAN1, Chunyu CHEN2, Dandan ZHAO2, Meng ZHANG2, Junlong WANG1, *, Na NI1, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China
出版时间: 2024-04-10 doi: 10.13683/j.wph.2024.04.004
文章导航
收藏切换

A型血友病(hemophilia A,HA)是一种罕见的X染色体连锁隐性遗传性出血性疾病,因血液中凝血因子Ⅷ(factorⅧ,FⅧ)缺乏或者功能障碍所致。其发病率低,治疗费用高,且目前暂无有效的根治方法,按需替代治疗仍然是我国治疗HA最有效的方式。但目前HA患者需要终身用药,现有的药物半衰期短、注射频次高,易产生FⅧ抑制物,且患者的生存质量差。针对这种未被满足的临床需求,该文主要综述血源性人FⅧ、重组人FⅧ及长效重组人FⅧ-Fc融合蛋白3种替代治疗药物的临床研究进展,为后期药物研发及临床治疗提供新的思路和依据。

A型血友病  /  替代治疗  /  血源性人凝血因子Ⅷ  /  重组人凝血因子Ⅷ  /  长效重组人凝血因子Ⅷ-Fc融合蛋白

Hemophilia A (HA) is a rare X-chromosome linked recessive hemorrhagic disorder caused by the deficiency or dysfunction of coagulation factor Ⅷ (FⅧ) in the blood. The incidence of HA is low, the cost of treatment is high, and there is no effective radical treatment at present. On-demand alternative treatment is still the most effective way to treat HA in our country. However, HA patients need lifelong medication, the existing drugs have short half-life, high injection frequency, easy to produce coagulation FⅧ inhibitors, and poor quality of life of patients. In view of such unmet clinical needs, this paper mainly reviewed the clinical research progress of three alternative therapeutic drugs: plasma-derived human coagulation FⅧ, recombinant human coagulation FⅧ and long-acting recombinant human coagulation FⅧFc fusion protein, to provide new ideas and basis for later drug development and clinical treatment.

hemophilia A  /  replacement therapy  /  plasma-derived human coagulation factor Ⅷ  /  recombinant human coagulation factor Ⅷ  /  reombint human coagulation factor Ⅷ-Fc fusion protein
兰志龙, 陈春宇, 赵丹丹, 张梦, 王俊龙, 倪娜. A型血友病替代治疗药物凝血因子Ⅷ的临床研究进展. 世界临床药物, 2024 , 45 (4) : 368 -371 . DOI: 10.13683/j.wph.2024.04.004
Zhilong LAN, Chunyu CHEN, Dandan ZHAO, Meng ZHANG, Junlong WANG, Na NI. Advances of clinical research on alternative therapy for hemophilia A, coagulation factor Ⅷ[J]. World Clinical Drug, 2024 , 45 (4) : 368 -371 . DOI: 10.13683/j.wph.2024.04.004

参考文献 引证文献
排序方式:
[1]
Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia[J]. Haemophilia, 2013, 19(1): e1-e47.
[2]
Schmitt C, Mancuso ME, Chang T, et al. Emicizumab dose up-titration in case of suboptimal bleeding control in people with haemophilia A[J]. Haemophilia, 2023, 29(1): 90-99
[3]
Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications[J]. Lancet, 2016, 388(10040): 187-197.
[4]
中华人民共和国国家卫生健康委员会. 血友病A诊疗指南(2022年版)[J]. 全科医学临床与教育, 2022, 20(7): 579-583.
[5]
屈泽欣, 肖剑文. 血友病A的治疗进展[J]. 临床医学进展, 2023, 13(3): 3973-3978.
[6]
王稳, 胡群. 血友病患者关节评估及治疗的研究进展[J]. 国际输血及血液学杂志, 2021, 44(5): 456-460.
[7]
Milanesio M, Tabares AH, Caeiro GA, et al. Acquired hemophilia[J]. Rev Fac Cien Med Univ Nac Cordoba, 2022, 79(1): 57-60.
[8]
陈如意, 吴燕, 刘依润, 等. 评价人凝血因子Ⅷ治疗甲型血友病患者的有效性和安全性[J]. 中国输血杂志, 2022, 35(12): 1220-1225.
[9]
Ebbert PT, Xavier F, Seaman CD, et al. Emicizumab prophylaxisin patients with haemophilia A with and without inhibitors[J]. Haemophilia, 2020, 26(1): 41-46.
[10]
杨仁池. 甲型血友病患者预防治疗的重要性[J]. 临床药物治疗杂志, 2019, 17(11): 11-13.
[11]
张建华, 董春霞, 张爱荣, 等. 血浆源性人凝血因子Ⅷ治疗血友病A有效性和安全性多中心Ⅲ期临床研究[J]. 中华内科杂志, 2016, 55(8): 624-627.
[12]
Wynn TT, Gumuscu B. Potential role of a new PEGylated recombinant factor Ⅷ for hemophilia A[J]. J Blood Med, 2016, 7: 121-128.
[13]
国家药品监督管理局药品审评中心. 注射用重组人凝血因子Ⅷ(CXSS1900043)申请上市技术审评报告[EB/OL]. [2024-01-09]. https://www.cde.org.cn/main/xxgk/postmarketpage?acceptidCODE=19ca9a9923f87cc8eb8fbd759529a9f4.
[14]
Chhabra ES, Liu T, Kulman J, et al. BIVV001, a new class of factor Ⅷ replacement for hemophilia A that is independent of von willebrand factor in primates and mice[J]. Blood, 2020, 135(17): 1484-1496.
[15]
周琪. 重组人凝血因子Ⅷ预防治疗甘肃地区重型血友病A患者的有效性和安全性观察[D]. 兰州: 兰州大学, 2020.
[16]
Quon DV, Klamroth R, Kulkarni R, et al. Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor Ⅷ Fc fusion protein (rFⅧFc) in the A-LONG and kids A-LONG studies[J]. Haemophilia, 2017, 23(1): e39-e42.
[17]
European Medicines Agency. First gene therapy to treat severe haemophilia A.[EB/OL]. [2024-01-09]. https://www.ema.europa.eu/en/news/first-gene-therapy-treat-severe-haemophilia.
[18]
Frampton JE. Efmoroctocog α: a review in haemophilia A[J]. Drugs, 2021, 81(17): 2035-2046.
[19]
Peters RT, Toby G, Lu Q, et al. Biochemical and functional characterization of a recombinant monomeric factor Ⅷ-Fc fusion protein[J]. J Thromb Haemost, 2013, 11(1): 132-141.
[20]
Tiede A. Half-life extended factor Ⅷ for the treatment of hemophilia A[J]. J Thromb Haemost, 2015, 13(Suppl 1): S176-S179.
[21]
Xue F, Chen Y, Sun J, et al. A phase 1 study to evaluate the pharmacokinetics and safety of a PEGylated-recombinant human coagulation factor Ⅷ-Fc fusion protein in patients with severe hemophilia A[EB/OL]. [2024-01-09]. https://isth2023.eventscribe.net/fsPopup.asp?PresentationID=1257997&mode=presInfo.
[22]
Mahlangu J, Powell JS, Ragni MV, et al. Phase 3 study of recombinant factor Ⅷ Fc fusion protein in severe hemophilia A[J]. Blood, 2014, 123(3): 317-325.
2024年第45卷第4期
23
6
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.04.004
  • 接收时间:2024-01-09
  • 首发时间:2026-11-17
  • 出版时间:2024-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-09
基金
作者信息
    1.中国医药工业研究总院药物临床研究中心,上海 200437
    2.上海益临思医药开发有限公司,上海 200437

通讯作者:

倪娜,副研究员,研究方向:创新药物的临床研究。
王俊龙,副研究员,研究方向:创新药物的临床研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.04.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏